NSETrading Window1h ago · 22 Sept 2026, 03:07 pm

Trading Window

Indraprastha Medical Corporation Limited · INDRAMEDCO

✦ AI Summary

Indraprastha Medical Corporation Limited has informed the Exchange about the closure of the trading window for designated persons, including promoters, directors, and key managerial personnel, from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending September 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Indraprastha Medical Corporation Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

INDRAMEDCO_22092026150729_IMCLWINDOWCLOSURE22092026.pdf

pdf

Download →
View document text
Indraprastha Medical Corporation Limited (Indraprastha Apollo Hospitals) Regd. Office : Sarita Vihar, Delhi-Mathura Road, New Delhi – 110 076 (India) Corporate Identity Number : L24232DL1988PLC030958 Phone:91-11-26925858,26925801,Fax: 91-11-26823629 E-mail: imclshares@apollohospitals.com, Website : https://www.apollohospitals.com/delhi/ Ref: IMCL/CS/TW/2026 22nd September, 2026 The Manager The Manager Listing Department Listing Department BSE Limited Phiroze Jeejeebhoy Towers National Stock Exchange of India Limited Dalal Street, Mumbai, Maharashtra - Exchange Plaza, C-1, Block G, 400001 Bandra Kurla Complex, Bandra East, Scrip Code: 532150 Mumbai, Maharashtra – 400051 Symbol: INDRAMEDCO Dear Sir, Pursuant to provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that the trading window for dealing in shares of the Company shall remain closed for all designated persons including Promoters, Directors, Key Managerial Personnel, Designated Employees and their connected persons from Thursday, 1st October, 2026, until 48 hours after the declaration of the unaudited financial results by the Company, for quarter ending 30th September, 2026. During the period of closure of Trading Window, the Permanent Account Number of all designated persons and their connected persons will remain frozen for trade in securities of the Company. The date of the Board Meeting to consider and approve the unaudited financial results for the quarter ending 30th September, 2026, will be intimated in due course. This is for your information and record. Thanking You, Sincerely Yours, For Indraprastha Medical Corporation Limited Priya Ranjan AVP – Corporate Affairs & Legal (Company Secretary & Compliance Officer)